M&A Deal Summary

Horizon Medical Products Acquires Cryolife - IFM Product Lines

On September 18, 1998, Horizon Medical Products acquired medical products company Cryolife - IFM Product Lines from Artivion for 15M USD

Acquisition Highlights
  • This is Horizon Medical Products’ 1st transaction in the Medical Products sector.
  • This is Horizon Medical Products’ largest (disclosed) transaction.
  • This is Horizon Medical Products’ 1st transaction in the United States.

M&A Deal Summary
Date 1998-09-18
Target Cryolife - IFM Product Lines
Sector Medical Products
Buyer(s) Horizon Medical Products
Sellers(s) Artivion
Deal Type Divestiture
Deal Value 15M USD

Target

Cryolife - IFM Product Lines

United States
Cryolife - IFM Product Lines consists of single use medical devices such as carotid shunts, which divert blood through arteries while surgeons remove plaque in the carotid artery, and embolectomy catheters used to remove emboli from dialysis access grafts.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Horizon Medical Products

Manchester, Georgia, United States
Category Company
Founded 1990
Sector Medical Products
DESCRIPTION

Horizon Medical Products, Inc. is a specialty medical device company that manufactures and markets vascular access prod- ucts.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (1998) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Artivion

Kennesaw, Georgia, United States
Category Company
Founded 1984
Sector Medical Products
Employees1,500
Revenue 354M USD (2023)
DESCRIPTION

Artivion is a manufacturer, processor, and distributor of implantable living tissues and medical devices used in cardiac and vascular surgical procedures. Artivion was incorporated in 1984 and is based in Kennesaw, Georgia.

DEAL STATS #
Overall 1 of 4
Sector (Medical Products) 1 of 3
Type (Divestiture) 1 of 4
Country (United States) 1 of 4
Year (1998) 1 of 1
Size (of disclosed) 3 of 3
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-17 CardioGenesis

Irvine, California, United States

CardioGenesis Corporation develops laser transmyocardial revascularization technologies for the treatment of angina and ischemic cardiac disease.

Buy $22M
Mergr

Product

Company

Legal